Science Explorer Back to mapMap
Discussion
Company · Ghent · Belgium

Q-Biologicals (Belgium)

Research works
11
▼ 11% vs 2018-21
Citations
324
30.2 per fractional work
Top-10% rate
76.9%
all institutions 10.0%
Open access
46%
world 40%
International
69%
world 18%

Not ranked overall: Q-Biologicals (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Q-Biologicals (Belgium) work in?

In all years, 49% of research at Q-Biologicals (Belgium) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (47%), Immunology and Microbiology (16%), Biochemistry, Genetics and Molecular Biology (12%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 49.3% of its workMedicine: 5 fractional works · 47.0% of its workEpidemiology: 3 fractional works · 24.7% of its workInfectious Diseases: 1 fractional works · 6.5% of its workHepatology: 0 fractional works · 4.1% of its workOtorhinolaryngology: 0 fractional works · 2.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.6% of its workOncology: 0 fractional works · 1.4% of its workRheumatology: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.5% of its workSurgery: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 2.3% of its workOccupational Therapy: 0 fractional works · 1.6% of its workSpeech and Hearing: 0 fractional works · 0.7% of its workLife Sciences: 3 fractional works · 32.5% of its workImmunology and Microbiology: 2 fractional works · 16.0% of its workMicrobiology: 1 fractional works · 9.9% of its workImmunology: 1 fractional works · 5.1% of its workVirology: 0 fractional works · 1.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 12.1% of its workMolecular Biology: 1 fractional works · 9.5% of its workGenetics: 0 fractional works · 1.5% of its workEndocrinology: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 2.6% of its workAnimal Science and Zoology: 0 fractional works · 1.6% of its workPlant Science: 0 fractional works · 1.0% of its workNeuroscience: 0 fractional works · 1.3% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workSensory Systems: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workPhysical Sciences: 2 fractional works · 15.3% of its workEngineering: 1 fractional works · 6.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.6% of its workMechanical Engineering: 0 fractional works · 1.6% of its workElectrical and Electronic Engineering: 0 fractional works · 1.0% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workMechanics of Materials: 0 fractional works · 0.7% of its workEnvironmental Science: 0 fractional works · 3.7% of its workEcology: 0 fractional works · 2.7% of its workGlobal and Planetary Change: 0 fractional works · 1.0% of its workChemistry: 0 fractional works · 3.2% of its workOrganic Chemistry: 0 fractional works · 1.5% of its workPhysical and Theoretical Chemistry: 0 fractional works · 1.0% of its workSpectroscopy: 0 fractional works · 0.7% of its workComputer Science: 0 fractional works · 1.7% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.0% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 3.0% of its workSocial Sciences: 0 fractional works · 3.0% of its workHealth: 0 fractional works · 2.4% of its workSociology and Political Science: 0 fractional works · 0.6% of its workALL ITS WORKQ-Biologicals(Belgium)11fractional works, all years
Life Sciences32%Physical Sciences15%Health Sciences49%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine547.0%
    2. Health Professions02.3%
    1. Immunology and Microbiology216.0%
    2. Biochemistry, Genetics and Molecular Biology112.1%
    3. Agricultural and Biological Sciences02.6%
    4. Neuroscience01.3%
    5. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Engineering16.4%
    2. Environmental Science03.7%
    3. Chemistry03.2%
    4. Computer Science01.7%
    5. Mathematics00.3%
    1. Social Sciences03.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Q-Biologicals (Belgium)?

The most cited paper from Q-Biologicals (Belgium) is "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017" (Christina Fitzmaurice et al., 2019), with 2,699 citations. Next come "The Tn 3 -family of Replicative Transposons" (147) and "A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers" (146).

Most cited papers
#PaperReleasedCitations
1 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors 27 Sep 2019 2,699
2 The Tn 3 -family of Replicative Transposons Émilien Nicolas, Michaël Lambin, Damien Dandoy et al. · Microbiology Spectrum Open access 29 Jun 2015 147
3 A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers Rigmor Thorstensson, Birger Trollfors, Nabil G. Al‐Tawil et al. · PLoS ONE Open access 8 Jan 2014 146
4 Septal and lateral wall localization of PBP5, the major D,D‐carboxypeptidase of Escherichia coli, requires substrate recognition and membrane attachment Lakshmi‐Prasad Potluri, Aneta Karczmarek, Jolanda Verheul et al. · Molecular Microbiology Open access 7 Jun 2010 93
5 Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen et al. · BMJ Open Open access Aug 2017 90
All 40 most cited papers, with filters and sorting

Which research topics does Q-Biologicals (Belgium) publish most on?

By volume in 2022-now: Intracerebral and Subarachnoid Hemorrhage Research, Dysphagia Assessment and Management, Acute Ischemic Stroke Management and Hearing, Cochlea, Tinnitus, Genetics.

  1. 1 Intracerebral and Subarachnoid Hemorrhage Research Neurology 0 works
  2. 2 Dysphagia Assessment and Management Speech and Hearing 0 works
  3. 3 Acute Ischemic Stroke Management Epidemiology 0 works
  4. 4 Hearing, Cochlea, Tinnitus, Genetics Sensory Systems 0 works
  5. 5 Vestibular and auditory disorders Neurology 0 works
  6. 6 Hearing Loss and Rehabilitation Cognitive Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.5%not open53.5%

World: 40% of research is openly available.

with international co-authors68.9%domestic only31.1%

World: 18% is written across borders.

How has Q-Biologicals (Belgium)'s research output changed?

Output in 2022-2025 was 11% lower than in 2018-2021.

1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Q-Biologicals (Belgium) as a percentage of every work published that year, 0.0000046% in 2023.

0.00010%0.00020%Q-Biologicals (Belgium)0.0000025% in 20241990200020102020

Fractional works of Q-Biologicals (Belgium) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Ghent

All research institutions in Ghent

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Q-Biologicals (Belgium). Posts are plain text and can be reported.